Literature DB >> 22434481

Different clonal origin of bilateral papillary thyroid carcinoma, with a review of the literature.

Elisabetta Kuhn1, Linda Teller, Simonetta Piana, Juan Rosai, Maria J Merino.   

Abstract

Papillary thyroid carcinoma (PTC) often presents with two or more anatomically separate foci. A long-standing argument is whether this multifocality is the result of multiple independent tumors ("multicentricity") or of intrathyroidal spread originating from a single tumor mass, presumably through permeation of intrathyroidal lymph vessels. We reexamined this issue with a clonality assay and compared our results with those in the literature. A total of 27 nodules from 11 female patients with bilateral PTC treated with total thyroidectomy were investigated for clonality using the HUMARA assay. Eight of 11 cases were informative (72.7 %). All but one of tumor foci showed a monoclonal population. The outlier sample gave a value indicative of balanced X-inactivation in one nodule. The monoclonality was concordant in three patients, discordant in three, and mixed in two (with both concordant and discordant results). Interestingly, in both of the latter cases (composed of over two samples per case), the contralateral nodules were discordant. Moreover, all four ipsilateral nodules were concordant. The results of our study suggest that some cases of multifocal PTC are the result of true multicentricity, whereas others are the consequence of intrathyroid spread by an originally single tumor mass. These conclusions support those made in the past years on the basis of morphologic considerations. Specifically, the incidental finding of two or more microscopic foci of PTC widely separate from each other was felt to favor multicentricity, whereas the finding of multiple ipsilateral foci of PTC within vascular spaces, often accompanied by multiple lymph node metastases, suggested intrathyroid spread; the most striking manifestation of this phenomenon being seen in the diffuse sclerosing variant of PTC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22434481      PMCID: PMC7478266          DOI: 10.1007/s12022-012-9202-2

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  17 in total

1.  THYROID CARCINOMA. CLASSIFICATION, INTRAGLANDULAR DISSEMINATION, AND CLINICOPATHOLOGICAL STUDY BASED UPON WHOLE ORGAN SECTIONS OF 80 GLANDS.

Authors:  W O RUSSELL; M L IBANEZ; R L CLARK; E C WHITE
Journal:  Cancer       Date:  1963-11       Impact factor: 6.860

2.  The many appearances of papillary carcinoma of the thyroid.

Authors:  W A Hawk; J B Hazard
Journal:  Cleve Clin Q       Date:  1976 WINTER

3.  Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas.

Authors:  Weibin Wang; Haiyong Wang; Xiaodong Teng; Haohao Wang; Chenyu Mao; Rongyue Teng; Wenhe Zhao; Jiang Cao; Thomas J Fahey; Lisong Teng
Journal:  Hum Pathol       Date:  2010-05-14       Impact factor: 3.466

4.  Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation.

Authors:  Sónia Moniz; Ana L Catarino; Ana R Marques; Branca Cavaco; Luís Sobrinho; Valeriano Leite
Journal:  Eur J Endocrinol       Date:  2002-01       Impact factor: 6.664

5.  Study of intraglandular dissemination of thyroid cancer.

Authors:  F Iida; M Yonekura; M Miyakawa
Journal:  Cancer       Date:  1969-10       Impact factor: 6.860

6.  Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma.

Authors:  Trisha M Shattuck; William H Westra; Paul W Ladenson; Andrew Arnold
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

7.  PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies.

Authors:  G L Mutter; K A Boynton
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

8.  Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients.

Authors:  R Katoh; J Sasaki; H Kurihara; K Suzuki; Y Iida; A Kawaoi
Journal:  Cancer       Date:  1992-09-15       Impact factor: 6.860

9.  Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy.

Authors:  M L Carcangiu; G Zampi; A Pupi; A Castagnoli; J Rosai
Journal:  Cancer       Date:  1985-02-15       Impact factor: 6.860

Review 10.  The demoiselle of X-inactivation: 50 years old and as trendy and mesmerising as ever.

Authors:  Céline Morey; Philip Avner
Journal:  PLoS Genet       Date:  2011-07-21       Impact factor: 5.917

View more
  17 in total

1.  BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study.

Authors:  Giovanni Tallini; Dario de Biase; Cosimo Durante; Giorgia Acquaviva; Michele Bisceglia; Rocco Bruno; Maria Letizia Bacchi Reggiani; Gian Piero Casadei; Giuseppe Costante; Nadia Cremonini; Livia Lamartina; Domenico Meringolo; Francesco Nardi; Annalisa Pession; Kerry J Rhoden; Giuseppe Ronga; Massimo Torlontano; Antonella Verrienti; Michela Visani; Sebastiano Filetti
Journal:  Mod Pathol       Date:  2015-08-14       Impact factor: 7.842

2.  Clinical characteristics and surgical resection of multifocal papillary thyroid carcinoma: 168 cases.

Authors:  Guomin Huang; Xiaofeng Tian; Yuhui Li; Fujian Ji
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Maurizio Iacobone; Svante Jansson; Marcin Barczyński; Peter Goretzki
Journal:  Langenbecks Arch Surg       Date:  2013-11-22       Impact factor: 3.445

4.  Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles.

Authors:  Zheming Lu; Jindong Sheng; Yujie Zhang; Jianhua Deng; Yong Li; Aiping Lu; Juan Zhang; Huan Yu; Min Zhang; Zikai Xiong; Hai Yan; Bill H Diplas; Youyong Lu; Baoguo Liu
Journal:  J Pathol       Date:  2016-04-01       Impact factor: 7.996

Review 5.  Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.

Authors:  Jinwei Hu; Isabella J Yuan; Saied Mirshahidi; Alfred Simental; Steve C Lee; Xiangpeng Yuan
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

6.  Multicentric occurrence of multiple papillary thyroid carcinomas--HUMARA and BRAF mutation analysis.

Authors:  Tadao Nakazawa; Tetsuo Kondo; Ippei Tahara; Kazunari Kasai; Tomohiro Inoue; Naoki Oishi; Kunio Mochizuki; Takeo Kubota; Ryohei Katoh
Journal:  Cancer Med       Date:  2015-04-17       Impact factor: 4.452

7.  Prognosis of multifocal papillary thyroid carcinoma.

Authors:  Sheng-Fong Kuo; Shu-Fu Lin; Tzu-Chieh Chao; Chuen Hsueh; Kun-Ju Lin; Jen-Der Lin
Journal:  Int J Endocrinol       Date:  2013-12-30       Impact factor: 3.257

8.  Ultrasonic features of papillary thyroid microcarcinoma and non-microcarcinoma.

Authors:  Xiao-Li Zhang; Lin-Xue Qian
Journal:  Exp Ther Med       Date:  2014-08-18       Impact factor: 2.447

9.  Predictive factors of contralateral occult carcinoma in patients with papillary thyroid carcinoma: a retrospective study.

Authors:  Xiaohang Chen; Zhenwei Zhong; Muye Song; Jiru Yuan; Ziyang Huang; Jialin Du; Yongchen Liu; Zeyu Wu
Journal:  Gland Surg       Date:  2020-08

10.  BRAF Testing in Multifocal Papillary Thyroid Carcinoma.

Authors:  Hillary Z Kimbrell; Andrew B Sholl; Swarnamala Ratnayaka; Shanker Japa; Michelle Lacey; Gandahari Carpio; Parisha Bhatia; Emad Kandil
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.